Fayez Sarofim & Co
HALO icon

Fayez Sarofim & Co’s Halozyme HALO Stock Holding History

Fayez Sarofim & Co’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$587K Hold
7,500
– – ﹤0.01% 218
2026
Q1 		$485K Hold
7,500
– – ﹤0.01% 228
2025
Q4 		$505K Hold
7,500
– – ﹤0.01% 229
2025
Q3 		$550K Hold
7,500
– – ﹤0.01% 228
2025
Q2 		$390K Hold
7,500
– – ﹤0.01% 248
2025
Q1 		$479K Hold
7,500
– – ﹤0.01% 232
2024
Q4 		$359K Buy
+7,500
New +$385K ﹤0.01% 253

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Fayez Sarofim & Co's HALO Position: Q2 2026 in Review

Fayez Sarofim & Co held its Halozyme (HALO) position steady in Q2 2026 at 7,500 shares worth $587K. The position accounts for ﹤0.01% of the portfolio, ranked #218.

Fayez Sarofim & Co first reported a position in HALO in Q4 2024 and has held it in 7 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Fayez Sarofim & Co held 7,500 shares of Halozyme worth $587K as of Q2 2026.
  • Fayez Sarofim & Co left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up ﹤0.01% of Fayez Sarofim & Co's portfolio in Q2 2026, its #218 holding.
  • Fayez Sarofim & Co first reported a position in Halozyme in Q4 2024 and has held it in 7 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Fayez Sarofim & Co's 13F filing for Q2 2026, filed 17 Aug 2026.